Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons prof. dr. A.A. (Adriaan) Voors

Publicaties

Biomarker and transcriptomics profiles of serum selenium concentrations in patients with heart failure are associated with immunoregulatory processes

Clinical characteristics and prognosis of patients with heart failure and high concentrations of interleukin-17D

Differential biomarker expression in heart failure patients with and without mitral regurgitation: Insights from BIOSTAT-CHF

Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: A phenomics approach

Epicardial adipose tissue and pericardial constraint in heart failure with preserved ejection fraction

Optimization of Evidence-Based Heart Failure Medications After an Acute Heart Failure Admission: A Secondary Analysis of the STRONG-HF Randomized Clinical Trial

Prediction of the Individual Aortic Stenosis Progression Rate and its Association With Clinical Outcomes

A First-in-Human Study of AMG 986, a Novel Apelin Receptor Agonist, in Healthy Subjects and Heart Failure Patients

Albuminuria as a marker of systemic congestion in patients with heart failure( )

Assessment of Biomarkers of Myocardial injury, Inflammation, and Renal Function in Heart Failure With Reduced Ejection Fraction: The VICTORIA Biomarker Substudy

Lees meer

Pers/media

SERENADE: No Benefit, Possible Harm With Macitentan in HFpEF and PAH

Novità nel trattamento dello scompenso cardiaco acuto

Empagliflozin benefits adults hospitalised for acute heart failure, shows study

Health Industry News

PRNewswire Latest Health News

EMPULSE shows empagliflozin benefit in acute heart failure

Journal of Cardiac Failure Launches Rapid Publication Platform to Spark Discourse

Dr Adriaan Voors: Health Care Reimbursement May Affect SGLT2 Inhibitor Uptake

Lees meer